INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

Curcumin dose titration was well tolerated in children with inflammatory bowel disease.

Children and adolescents with mild or remissive Crohn disease or ulcerative colitis received adjunctive curcumin escalated every three weeks from 500 mg to 1 g and finally 2 g twice daily. Curcumin was tolerated well across the 9-week evaluation, with increased gassiness noted in only two participants across all visits. Additionally, three individuals experienced improvements in validated disease activity scores.

Study type
Prospective dose-titration study
Who was studied
Pediatric patients with Crohn disease or ulcerative colitis in remission or with mild disease
What was measured
Tolerability, side effects, and disease activity

THE PAPER

Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.

Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. J Pediatr Gastroenterol Nutr, 2013.

PubMed 23059643 ↗DOI 10.1097/MPG.0b013e318276977d ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.